Filtered By:
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 2139 results found since Jan 2013.
Screening for cervical cancer, human papillomavirus (HPV) vaccination
Magy Onkol. 2022 Dec 31;66(4):325-330. Epub 2022 Aug 21.ABSTRACTCervical cancer screening is widely used worldwide, which led to a significant decrease both in incidence and mortality of the disease in several countries. Cervical cancer screening was introduced in the 1950s as opportunistic method for secondary prevention of cervical cancer in Hungary, later, however, became a part of National Immunization Program. Detection of human papillomavirus (HPV) is the first-line method of screening in several countries before cytology, which has been proposed to be introduced in Hungary by several groups. The incidence and mortal...
Source: Magyar Onkologia - May 10, 2023 Category: Cancer & Oncology Authors: Zsuzsa Schaff Bal ázs Járay Source Type: research
The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China
Eur J Obstet Gynecol Reprod Biol. 2023 Apr 19;286:10-15. doi: 10.1016/j.ejogrb.2023.04.014. Online ahead of print.ABSTRACTHigh-risk human papillomavirus (hrHPV) infection is the cause of most cervical cancers. Since therapeutic vaccines are not yet available for clinical practice, the administration of HPV prophylactic vaccines in patients with cervical intraepithelial neoplasia (CIN) arouses great interest and its value after excisional treatment of CIN remains unclear. We conducted this prospective cohort study to evaluate the impact of HPV prophylactic vaccination on preventing women from subsequent infection and cervic...
Source: Reproductive Biology - May 9, 2023 Category: Reproduction Medicine Authors: Ming Chen Cheng Li Qiulin Cui Chengli Zhou Peisong Chen Shuzhong Yao Source Type: research
Epidemiology of Upper Limb Complex Regional Pain Syndrome in a Retrospective Cohort of Persons Aged 9-30 Years, 2002-2017
Conclusion These data provide a comprehensive assessment of the epidemiology and characteristics of CRPS in children and young adults and provide further reassurance about the safety of HPV vaccination.PMID:37154719 | DOI:10.7812/TPP/22.170
Source: Cancer Control - May 8, 2023 Category: Cancer & Oncology Authors: Allison L Naleway Michelle L Henninger Stephanie A Irving S Bianca Salas Tia L Kauffman Bradley Crane Kathleen F Mittendorf Stacy Harsh Charles Elder Julianne Gee Source Type: research
Human papillomavirus vaccine administration among women in the Eastern Mediterranean region of Turkey: prevalence and barriers
CONCLUSIONS: The most important barriers to HPV vaccination were the lack of public funding for vaccines and the lack of information. We recommend increasing educational activities on the HPV vaccination program and public funding of vaccination.PMID:37140303 | DOI:10.26355/eurrev_202304_32126
Source: Pharmacological Reviews - May 4, 2023 Category: Drugs & Pharmacology Authors: B Mete F A Utuk H Demirhindi A Inaltekin F Tan ır E Kara E Nazl ıcan Source Type: research
Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen
Hum Vaccin Immunother. 2023 Dec 31;19(1):2204784. doi: 10.1080/21645515.2023.2204784.ABSTRACTHuman papillomavirus (HPV) vaccination uptake in the United States remains suboptimal, and continues to trail that of tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and quadrivalent meningococcal conjugate vaccination (MCV4). This is despite these three vaccines all being recommended for routine adolescent use within the 2005-2006 time period. One strategy to improve HPV vaccination is starting the vaccine series at the first opportunity - currently as young as 9 years of age. Little is known about the epidemiology...
Source: Cancer Control - May 4, 2023 Category: Cancer & Oncology Authors: Robert A Bednarczyk Heather M Brandt Source Type: research
Human papillomavirus vaccine administration among women in the Eastern Mediterranean region of Turkey: prevalence and barriers
CONCLUSIONS: The most important barriers to HPV vaccination were the lack of public funding for vaccines and the lack of information. We recommend increasing educational activities on the HPV vaccination program and public funding of vaccination.PMID:37140303 | DOI:10.26355/eurrev_202304_32126
Source: Pharmacological Reviews - May 4, 2023 Category: Drugs & Pharmacology Authors: B Mete F A Utuk H Demirhindi A Inaltekin F Tan ır E Kara E Nazl ıcan Source Type: research
Identification of subgroups in the Danish population for targeted human papillomavirus vaccination efforts
CONCLUSION: To increase the HPV vaccination uptake, we recommend vaccination efforts targeting girls living without any of their parents, girls attending special need education, immigrants, and girls who are not DTaP-IPV revaccinated. When targeting immigrants, the effort should focus on disseminating sufficient and understandable information about the Danish childhood vaccination program to the parents.PMID:37142460 | DOI:10.1016/j.vaccine.2023.04.060
Source: Vaccine - May 4, 2023 Category: Allergy & Immunology Authors: Sidsel Skou Voss Sarah Kristine N ørgaard Palle Valentiner-Branth Source Type: research
Kikuchi-Fujimoto Disease: a rare type of lymphadenopathy and its plausible relationship with human papillomavirus vaccines
Rev Esp Quimioter. 2023 May 3:rodriguez03may2023. doi: 10.37201/req/140.2022. Online ahead of print.NO ABSTRACTPMID:37130334 | DOI:10.37201/req/140.2022
Source: Revista Espanola de Quimioterapia - May 2, 2023 Category: Drugs & Pharmacology Authors: A Rodr íguez-Ferreras I Maray C Coya-Fern ández M M Octavio-Bocigas M F Fern ández-Del Río S Casares-L ópez J Ruiz-Salazar Source Type: research
Engaging Multistakeholder Perspectives to Identify Patient-Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune Conditions
CONCLUSION: A multistakeholder group identified key topics as critically important priorities for future research to decrease vaccine hesitancy and improve uptake of vaccines for adults with autoimmune conditions.PMID:37127530 | DOI:10.1002/acr2.11546
Source: Herpes - May 1, 2023 Category: Infectious Diseases Authors: Shilpa Venkatachalam Kelly Gavigan Laura Stradford Vandana Dronadula Angela Degrassi W Benjamin Nowell Shubhasree Banerjee Peter A Merkel Michael D George Jennifer Gordon Dianne G Shaw Kalen Larsen Lisa Emrich Robert N McBurney Hope Sullivan Ashira Blazer Source Type: research
Parental knowledge, views, and perceptions of human papilloma virus infection and vaccination-cross-sectional descriptive study
CONCLUSION: Parents in the present study demonstrated a substantial lack of knowledge about HPV infection and vaccination, which may necessitate the establishment of national awareness campaigns.PMID:37122659 | PMC:PMC10131950 | DOI:10.4103/jfmpc.jfmpc_1673_22
Source: Primary Care - May 1, 2023 Category: Primary Care Authors: Mansour A Tobaiqy Safaa A Mehdar Tasneem I Altayeb Tala M Saad Sulafa T Alqutub Source Type: research
Engaging Multistakeholder Perspectives to Identify Patient-Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune Conditions
CONCLUSION: A multistakeholder group identified key topics as critically important priorities for future research to decrease vaccine hesitancy and improve uptake of vaccines for adults with autoimmune conditions.PMID:37127530 | DOI:10.1002/acr2.11546
Source: Herpes - May 1, 2023 Category: Infectious Diseases Authors: Shilpa Venkatachalam Kelly Gavigan Laura Stradford Vandana Dronadula Angela Degrassi W Benjamin Nowell Shubhasree Banerjee Peter A Merkel Michael D George Jennifer Gordon Dianne G Shaw Kalen Larsen Lisa Emrich Robert N McBurney Hope Sullivan Ashira Blazer Source Type: research
Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer
Oncol Rep. 2023 Jun;49(6):118. doi: 10.3892/or.2023.8555. Epub 2023 Apr 28.ABSTRACTCervical cancer (CC) is a multifactorial disease of which human papillomavirus (HPV) is the main etiological agent. Despite cervical Pap smear screening and anti‑HPV vaccination, CC remains a major public health issue. Identification of specific gene expression signatures in the blood could allow better insight into the immune response of CC and could provide valuable information for the development of novel biomarkers. The present study performed a transcriptomic analysis of peripheral blood mononuclear cells (PBMCs) from Senegalese patie...
Source: Cancer Control - April 28, 2023 Category: Cancer & Oncology Authors: Moussa Ndiaye Gora Diop Celine Derbois Jean-Louis Spadoni Josselin Noirel Raissa Medina-Santos Cedric Coulonges Magali Torres Alioune Dieye Mbacke Sembene Jean-Fran çois Deleuze Alain Toledano Ahmadou Dem Jean-Fran çois Zagury Sigrid Le Clerc Source Type: research
